Nasus Pharma Ltd. (NSRX) Stock Overview
Explore Nasus Pharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Nasus Pharma Ltd. (NSRX)
Key Financials
Key Financials
Market Cap
29.4M
P/E Ratio
-20.00
EPS (TTM)
$-0.72
ROE
0.00%
NSRX Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Nasus Pharma Ltd. (AMEX: NSRX) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Nasus Pharma Ltd.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NSRX on the AMEX shows an RSI of 57.86, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.09 for the AMEX listing.
Key metrics behind Nasus Pharma Ltd.'s AMEX-traded stock include a P/E ratio of -20.00 and a market capitalization of 29.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NSRX on the AMEX.